These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2905771)

  • 1. [Treatment continuity in schizophrenic patients in ambulatory care. A 5-year follow-up].
    Gmür M; Tschopp A
    Nervenarzt; 1988 Dec; 59(12):727-30. PubMed ID: 2905771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depot neuroleptics in social psychiatric practice].
    Pruss U; Rose HK; Zechner A
    Psychiatr Prax; 1984 Jul; 11(4):101-8. PubMed ID: 6148764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacoeconomic model of outpatient antipsychotic therapy in "revolving door" schizophrenic patients.
    Glazer WM; Ereshefsky L
    J Clin Psychiatry; 1996 Aug; 57(8):337-45. PubMed ID: 8752015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuity of care after inpatient discharge of patients with schizophrenia in the Medicaid program: a retrospective longitudinal cohort analysis.
    Olfson M; Marcus SC; Doshi JA
    J Clin Psychiatry; 2010 Jul; 71(7):831-8. PubMed ID: 20441730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Modification of long-term schizophrenia by somato-therapeutic measures].
    Gross G; Huber G; Schüttler R
    Psychiatr Clin (Basel); 1980; 13(3-4):179-92. PubMed ID: 6113621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The risk of rehospitalisation during therapy with atypical and typical neuroleptics--a contribution to differential indication].
    Müller P; Nerenz H; Schaefer E
    Psychiatr Prax; 2002 Oct; 29(7):388-91. PubMed ID: 12378421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Outpatient prescription of atypical antipsychotics for schizophrenic patients after discharge from hospital treatment].
    Schäfer I; Lauterwein N; Karow A; Naber D
    Psychiatr Prax; 2004 Mar; 31(2):74-7. PubMed ID: 14983394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The attitude of patients towards antipsychotic depot treatment.
    Heres S; Schmitz FS; Leucht S; Pajonk FG
    Int Clin Psychopharmacol; 2007 Sep; 22(5):275-82. PubMed ID: 17690596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The psychoprophylactic importance of treatment with depot neuroleptics in schizophrenia].
    Chiriţă V; Stanciu J; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(3):497-500. PubMed ID: 2576888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depot neuroleptic therapy: clinical considerations.
    Remington GJ; Adams ME
    Can J Psychiatry; 1995 Apr; 40(3 Suppl 1):S5-11. PubMed ID: 7627927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects and side effects of depot neuroleptics as perceived by patients].
    Trenckmann U
    Psychiatr Prax; 1990 Sep; 17(5):184-7. PubMed ID: 1980015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic efficacy of long-acting vs. short-acting neuroleptics in schizophrenic out-patients (author's transl)].
    Tegeler J; Lehmann E; Stockschlaeder M
    Nervenarzt; 1980 Nov; 51(11):654-61. PubMed ID: 6109262
    [No Abstract]   [Full Text] [Related]  

  • 14. Relapse and rehospitalization: comparing oral and depot antipsychotics.
    Schooler NR
    J Clin Psychiatry; 2003; 64 Suppl 16():14-7. PubMed ID: 14680414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study on relapse of schizophrenic patients--10-year-follow-up investigation after initial admission].
    Uchida S
    Seishin Shinkeigaku Zasshi; 1996; 98(5):299-319. PubMed ID: 8741284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of treatments that can ameliorate nonadherence in patients with schizophrenia.
    Kane JM
    J Clin Psychiatry; 2006; 67 Suppl 5():9-14. PubMed ID: 16822091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are patients with schizophrenia under-treated with second-generation antipsychotics? A pilot study of the prescription practices of German psychiatrists.
    Hamann J; Pfeiffer H; Leucht S; Kissling W
    Pharmacopsychiatry; 2003 Nov; 36(6):309-12. PubMed ID: 14663656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z; Britvić D; Vuković O; Ille T
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on the use of long-acting depot neuroleptic injections in the maintenance therapy of schizophrenia.
    Johnson DA
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):13-21. PubMed ID: 6143743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.